List Of Publications

1 5 6 7 8 9 10 11 16 24 31

K. Dáňová, A. Grohová, P. Strnadová, D.P. Funda, Z. Šumník, J. Lebl, O. Cinek, Š. Průhová, S. Koloušková, B. Obermannová, L. Petruželková, A. Šedivá, P. Fundová, K. Buschard, R. Špíšek, L. Palová-Jelínková.

Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.

J Immunol. 2017 Jan 15;198(2):729-740.

J. Fučíková, I. Truxová, M. Hensler, E. Becht, L. Kasíková, I. Moserová, S. Vošáhliková, J. Kloučková, S.E. Church, I. Cremer, O. Kepp, G. Kroemer, L. Galluzzi, C. Salek, R. Špíšek

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.

Blood. 2016 Dec 29;128(26):3113-3124. doi: 10.1182/blood-2016-08-731737. Epub 2016 Nov 1.

I. Truxová, M. Hensler, P. Skapa, M. J. Halaska, J. Laco, A. Ryška, R. Špíšek, J. Fučíková.

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.

Int Rev Cell Mol Biol. 2017;330:115-156.
This website uses cookies; by continuing to use this page, you consent to their use. About cookies